Kojic acid is a naturally derived fungal metabolite produced during the fermentation of certain fungi, including Aspergillus oryzae. It works as a skin-brightening agent by inhibiting tyrosinase, the enzyme responsible for melanin synthesis. In cosmetic body milks, it is considered safe for topical use when formulated within appropriate concentration limits and accompanied by a robust preservative and stabilisation system.
In the United States, the FDA does not set a specific maximum concentration for kojic acid in rinse-off or leave-on cosmetics, but regulatory and industry guidance — reinforced by the Cosmetic Ingredient Review (CIR) expert panel — treats concentrations up to 1–2% as the working standard for leave-on products such as body milks and lotions. Claims must remain cosmetic in nature; drug-type claims about treating or preventing any skin condition are prohibited.
In the European Union, the situation is more complex. The Scientific Committee on Consumer Safety (SCCS) has reviewed kojic acid multiple times. As of the most recent published opinion, kojic acid at up to 1% in face and hand products was considered safe, but the committee called for more data on leave-on body products applied to large surface areas. Several EU member-state regulatory authorities have adopted a precautionary 0.5–1% limit for body-applied leave-on products while the full annex decision is pending. Brands selling into the EU should consult a qualified safety assessor and obtain a current CPSR before launch.
Japan permits kojic acid up to 2% in quasi-drug products approved by the PMDA (Pharmaceuticals and Medical Devices Agency), making it one of the more permissive markets. South Korea regulates it as a functional cosmetic ingredient requiring separate functional cosmetic registration at concentrations with a brightening efficacy claim.
Formulation stability is the biggest technical challenge. Kojic acid is highly sensitive to pH — it is most stable and active at pH 3.5–5.0 — and oxidises to a dark brown colour on exposure to light, heat, or air. Manufacturers address this with chelating agents (EDTA), antioxidants (ascorbic acid, ferulic acid), UV-protective opaque or amber packaging, and airless dispensing systems. A well-formulated kojic acid body milk with proper packaging should maintain colour stability and potency for 18–24 months.
Skin sensitisation risk is low at cosmetic concentrations, but patch testing is advisable for consumers with compromised skin barriers. Formulas combining kojic acid with other brightening actives — alpha-arbutin, tranexamic acid, niacinamide — can achieve a synergistic brightening effect at lower individual concentrations, which also reduces any sensitisation risk and improves regulatory positioning across multiple markets.
Always request a full safety assessment, CoA, and challenge-test results from your manufacturer before launching.
Ingredients in this answer: Kojic Acid · Ascorbic Acid · Ferulic Acid · Tranexamic Acid · Alpha-Arbutin
Read the full guide on Private Label Kojic Acid Body Milk Manufacturer Low MOQ →